ABSTRACT
The year 2014 was rich in significant advances in all areas of internal medicine. Many of them have an impact on our daily practice and on the way we manage one problem or another. From the use of the ultrasound for the diagnosis of pneumonia to the choice of the site of venous access and the type of line, and the increasing complexity of choosing an oral anticoagulant agent, this selection offers to the readers a brief overview of the major advances. The chief residents in the Service of internal medicine of the Lausanne University hospital are pleased to share their readings.
Subject(s)
Internal Medicine/trends , Medical Staff, Hospital , Alzheimer Disease/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Anticoagulants/therapeutic use , Arterial Pressure/physiology , Catheterization, Central Venous , Diverticulitis/therapy , Emergency Service, Hospital , Hospitals, University , Humans , Hypertension/surgery , Idiopathic Pulmonary Fibrosis/drug therapy , Kidney/innervation , Pneumonia/diagnostic imaging , Pulmonary Embolism/diagnosis , Pyridones/therapeutic use , Shock, Septic/therapy , Sympathectomy/methods , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Ultrasonography , Venous Thromboembolism/drug therapy , Vitamin B 12 Deficiency/etiology , Vitamin E/therapeutic useABSTRACT
The year 2011 was full of significant advances in all areas of medicine. Whether small or large issues, they all have an impact on daily practice in general internal medicine. For example, intravenous administration of diuretics in heart failure shows no benefit. But double dose may improve symptoms faster. Direct Xa inhibitors are emerging as alternative to anti-vitamin K. beta-blockers reduce overall mortality in COPD and do not worsen lung function significantly. Each year, the chief residents from the Department of internal medicine at the University hospital of Lausanne meet to share their readings. Twelve new therapeutic considerations of 2011 are reviewed here.
